Cargando…
Human mesenchymal stromal cells and derived extracellular vesicles: Translational strategies to increase their proangiogenic potential for the treatment of cardiovascular disease
Mesenchymal stromal cells (MSCs) offer great potential for the treatment of cardiovascular diseases (CVDs) such as myocardial infarction and heart failure. Studies have revealed that the efficacy of MSCs is mainly attributed to their capacity to secrete numerous trophic factors that promote angiogen...
Autores principales: | Nazari‐Shafti, Timo Z., Neuber, Sebastian, Garcia Duran, Ana, Xu, Zhiyi, Beltsios, Eleftherios, Seifert, Martina, Falk, Volkmar, Stamm, Christof |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695640/ https://www.ncbi.nlm.nih.gov/pubmed/32761804 http://dx.doi.org/10.1002/sctm.19-0432 |
Ejemplares similares
-
MiRNA Profiles of Extracellular Vesicles Secreted by Mesenchymal Stromal Cells—Can They Predict Potential Off-Target Effects?
por: Nazari-Shafti, Timo Z., et al.
Publicado: (2020) -
Treatment of Cardiac Fibrosis with Extracellular Vesicles: What Is Missing for Clinical Translation?
por: Neuber, Sebastian, et al.
Publicado: (2023) -
Mesenchymal Stromal Cells Cultured in Serum from Heart Failure Patients Are More Resistant to Simulated Chronic and Acute Stress
por: Nazari-Shafti, Timo Z., et al.
Publicado: (2018) -
Impact of procedural variability and study design quality on the efficacy of cell-based therapies for heart failure - a meta-analysis
por: Xu, Zhiyi, et al.
Publicado: (2022) -
Hopes and Hurdles of Employing Mesenchymal Stromal Cells in the Treatment of Cardiac Fibrosis
por: Neuber, Sebastian, et al.
Publicado: (2021)